Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Enfusion Inc (NYSE: ENFN) closed the day trading at $10.69 up 1.04% from the previous closing price of $10.58. In other words, the price has increased by $1.04 from its previous closing price. On the day, 0.56 million shares were traded. ENFN stock price reached its highest trading level at $11.16 during the session, while it also had its lowest trading level at $10.47.
Ratios:
For a better understanding of ENFN, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 28.46 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 69.00. For the most recent quarter (mrq), Quick Ratio is recorded 3.62 and its Current Ratio is at 3.62. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.22.
On February 28, 2024, Goldman Downgraded its rating to Sell which previously was Neutral and also lowered its target price recommendation from $9 to $8.
JP Morgan Downgraded its Neutral to Underweight on January 30, 2024, whereas the target price for the stock was revised from $11 to $9.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 20 ’24 when Herring Bradley sold 24,443 shares for $10.61 per share. The transaction valued at 259,340 led to the insider holds 270,503 shares of the business.
Herring Bradley bought 24,443 shares of ENFN for $259,416 on Dec 20 ’24. On Dec 03 ’24, another insider, Pawar Neal, who serves as the Chief Operating Officer of the company, sold 26,246 shares for $10.09 each. As a result, the insider received 264,822 and left with 1,117,298 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ENFN now has a Market Capitalization of 1008837696 and an Enterprise Value of 1002258112. As of this moment, Enfusion’s Price-to-Earnings (P/E) ratio for their current fiscal year is 408.02, and their Forward P/E ratio for the next fiscal year is 36.89. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.04 while its Price-to-Book (P/B) ratio in mrq is 14.26. Its current Enterprise Value per Revenue stands at 5.136 whereas that against EBITDA is 54.097.
Stock Price History:
Over the past 52 weeks, ENFN has reached a high of $11.38, while it has fallen to a 52-week low of $7.52. The 50-Day Moving Average of the stock is 9.26%, while the 200-Day Moving Average is calculated to be 17.02%.
Shares Statistics:
Over the past 3-months, ENFN traded about 414.86K shares per day on average, while over the past 10 days, ENFN traded about 564660 shares per day. A total of 93.26M shares are outstanding, with a floating share count of 49.54M. Insiders hold about 47.50% of the company’s shares, while institutions hold 59.45% stake in the company. Shares short for ENFN as of 1732838400 were 820410 with a Short Ratio of 1.96, compared to 1730332800 on 1178460. Therefore, it implies a Short% of Shares Outstanding of 820410 and a Short% of Float of 1.7999999999999998.
